VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment 英文论文文献.docVIP

  • 3
  • 0
  • 约4.27万字
  • 约 11页
  • 2017-05-08 发布于上海
  • 举报

VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment 英文论文文献.doc

VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment 英文论文文献

Pattenetal.BMCCancer2010,10:683 /1471-2407/10/683 RESEARCH ARTICLE OpenAccess VEGFR2heterogeneityandresponseto anti-angiogeniclowdosemetronomic cyclophosphamidetreatment StevenGPatten,UnaAdamcic,KristenLacombe,KanwalMinhas,KarolinaSkowronski,BrendaLCoomber* Abstract Background:Targetingtumorvasculatureisastrategywithgreatpromiseinthetreatmentofmanycancers. However,anti-angiogenicreagentsthattargetVEGF/VEGFR2signalinghavemetwithvariableresultsclinically. Amongthepossiblereasonsforthismaybeheterogeneousexpressionofthetargetprotein. Methods:Doubleimmunofluorescentstainingwasperformedonformalin

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档